Arcturus Therapeutics Gets $1.3M

San Diego-based Arcturus Therapeutics, which is developing RNAi therapeutics to treat disease, said this morning that it has raised $1.3M in a seed fudning round. The company said the round came from multiple, high net-worth private investors from the U.S. and Canada. Names of those investors were not announced. Arcturus Therapeutics is headed by Joseph E. Payne. More information »